Loading Events

Heart Failure Summit

December 02, 2021

8:00 am CST -12:30 pm CST

The complexity of heart failure management is the focus of PCNA’s Virtual Heart Failure Summit, December 2, 2021. Heart failure is a chronic progressive disease affecting over 6.5 million Americans, and researchers expect the number to increase to eight million by the year 2030. Earn up to 2.25 continuing education contact hours when you join us in a deep dive into heart failure.

You will join the live event using this link.

Agenda

8:00 AM CSTWelcome
8:10 AM CSTNew and Emerging Treatments for HFrEF and HFpEF
Colleen McIlvennan PhD, DNP, ANP, FAHA, FHFSA
9:00 AM CSTTreatment of Recurrent Pericarditis
Kiniksa Product Theater
Jane A. Linderbaum MS , ARNP, FACC
10:00 AM CSTBreak
10:10 AM CSTHeart Failure and the Social Determinants of Health Part 1
Connie White-Williams, PhD, RN, NE-BC, FAAN
10:55 AM CSTHeart Failure and the Social Determinants of Health Part 2 Across Race and Gender
Nancy M. Albert, RN, PhD, FHFSA
10:35 AM CSTCase-Based Management of Patients with Symptomatic Hypertrophic Cardiomyopathy
Heidi Salisbury, RN, MS, CNS-BC, ACGN
12:25 PM CSTWrap-up

Learning Objectives

New and Emerging Treatments for HFrEF and HFpEF (0.85 CE contact hours)

  1. Review current guideline updates for heart failure management
  2. Provide an update on new and emerging treatment options for HFrEF and HFpEF
  3. Explain the role of SGLT2 inhibitors in heart failure management
  4. Discuss the application of shared decision making in treatment options for HFrEF and HFpEF

Managing Heart Failure in Hypertrophic Cardiomyopathy (Non-CE)

  1. Review the signs and symptoms of HCM, including diagnostic criteria
  2. Describe the clinical relationship between hypertrophic cardiomyopathy (HCM) and heart failure (HF)
  3. Discuss shared decision-making and treatment options for advanced HF in the HCM disease spectrum

Heart Failure and the Social Determinants of Health Part 1 (0.65 CE contact hours)

  1. Define social determinants of health
  2. Explain how the social determinants of health impact optimizing heart failure treatment
  3. Discuss the interventions addressing the impact of the social determinants of health on delivery of care and outcomes of patients with heart failure

Heart Failure and the Social Determinants of Health Part 2 Deep Dive (0.65 CE contact hours)

  1. Explore social detriments of health based on gender
  2. Explore social detriments of health based on race
  3. Discuss further interventions addressing improving delivery and outcomes of patients with heart failure

Supporters

Thank you to our event sponsors for help making this event possible:

  • Novartis Pharmaceuticals Corporation
  • Merck Sharpe & Dohme Corp.
  • Bristol-Myers Squibb
  • Kiniksa Pharmaceuticals

PCNA is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 03060